101 related articles for article (PubMed ID: 3491874)
1. Suramin treatment for chronic active hepatitis B--toxic and ineffective.
Loke RH; Anderson MG; Coleman JC; Tsiquaye KN; Zuckerman AJ; Murray-Lyon IM
J Med Virol; 1987 Jan; 21(1):97-9. PubMed ID: 3491874
[TBL] [Abstract][Full Text] [Related]
2. Suramin inhibits duck hepatitis B virus DNA polymerase activity.
Tsiquaye K; Zuckerman A
J Hepatol; 1985; 1(6):663-9. PubMed ID: 4056360
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of the polybasic anion, suramin and acyclovir in Hepadna virus infection.
Tsiquaye KN; Collins P; Zuckerman AJ
J Antimicrob Chemother; 1986 Oct; 18 Suppl B():223-8. PubMed ID: 3793662
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of ARA-AMP on serum DNA polymerase activity and serum HBV-DNA in chronic hepatitis B virus infection. A possible reason for lack of efficacy.
Alexander GJ; Fagan EA; Rolando N; Guarner P; Callender ME; Eddleston AL; Williams R
J Hepatol; 1986; 3 Suppl 2():S81-6. PubMed ID: 2439580
[TBL] [Abstract][Full Text] [Related]
5. Anti-hepatitis B virus activity of wogonin in vitro and in vivo.
Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J
Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723
[TBL] [Abstract][Full Text] [Related]
6. [Hepatitis B virus DNA polymerase activity in various clinical forms of HBV infection].
Loch T; Cianciara J
Pol Arch Med Wewn; 1992 Jun; 87(6):345-51. PubMed ID: 1408993
[TBL] [Abstract][Full Text] [Related]
7. Duck hepatitis B virus: DNA polymerase and reverse transcriptase activities of replicative complexes isolated from liver and their inhibition in vitro.
Offensperger WB; Walter E; Offensperger S; Zeschnigk C; Blum HE; Gerok W
Virology; 1988 May; 164(1):48-54. PubMed ID: 2452518
[TBL] [Abstract][Full Text] [Related]
8. Effects of suramin on in vitro HBsAg production by PLC/PRF/5 cells and hepatitis B virus DNA polymerase activity.
Kessler HA; Pottage JC; Trenholme GM; Benson CA; Levin S
AIDS Res; 1986 Feb; 2(1):63-72. PubMed ID: 2424468
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation.
Bain VG; Kneteman NM; Ma MM; Gutfreund K; Shapiro JA; Fischer K; Tipples G; Lee H; Jewell LD; Tyrrell DL
Transplantation; 1996 Nov; 62(10):1456-62. PubMed ID: 8958272
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological response of HBsAg-positive chronic active hepatitis to adenine arabinoside: lack of correlation with DNA polymerase response.
Liaw YF; Lin DY; Chen TJ; Chu CM; Sheen IS
Infection; 1984; 12(4):248-50. PubMed ID: 6490167
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and experimental studies on effects of chronic hepatitis B treated with astragali composita].
Liu KZ; Xu CH; Zhang MT
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Jul; 16(7):394-7. PubMed ID: 9387730
[TBL] [Abstract][Full Text] [Related]
12. Virus-associated receptors for polymerized human serum albumin (RpHSA) in patients with chronic active hepatitis B treated with recombinant leukocyte A interferon.
Gerken G; Manns M; Hess G; Meyer zum Büschenfelde KH
Digestion; 1987; 37(2):96-102. PubMed ID: 3040500
[TBL] [Abstract][Full Text] [Related]
13. Isoprinosine in the treatment of chronic active hepatitis type B.
Cianciara J; Laskus T; Gabinska E; Loch T
Scand J Infect Dis; 1990; 22(6):645-8. PubMed ID: 1704640
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of human leukocyte interferon on chronic active hepatitis B in children.
Hashida T; Sawada T; Esumi N; Kinugasa A; Kusunoki T; Kishida T
J Pediatr Gastroenterol Nutr; 1985 Feb; 4(1):20-5. PubMed ID: 3981364
[TBL] [Abstract][Full Text] [Related]
15. [Vidarabine treatment of chronic active hepatitis associated with hepatitis B virus multiplication. A randomized multicenter study].
Ouzan D; Degos F; Marcellin P; Linberg J; Chevallier M; Degott C; Bréchot C; Chossegros P; Weiss AM; Hirtz J
Gastroenterol Clin Biol; 1987; 11(8-9):568-73. PubMed ID: 3308617
[TBL] [Abstract][Full Text] [Related]
16. β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity.
Hu Y; Cheng X; Cao F; Huang A; Tavis JE
Antiviral Res; 2013 Sep; 99(3):221-9. PubMed ID: 23796982
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus and primary hepatocellular carcinoma: treatment of HBV carriers with Phyllanthus amarus.
Blumberg BS; Millman I; Venkateswaran PS; Thyagarajan SP
Vaccine; 1990 Mar; 8 Suppl():S86-92. PubMed ID: 2158192
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B.
Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H
Nephrol Dial Transplant; 1994; 9(7):820-3. PubMed ID: 7526277
[TBL] [Abstract][Full Text] [Related]
19. Design of new anti-viral agents for chronic hepatitis B virus infection.
Locarnini S
J Gastroenterol Hepatol; 1991; 6 Suppl 1():18-22. PubMed ID: 1751799
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy.
Kuhns MC; McNamara AL; Perrillo RP; Cabal CM; Campbel CR
J Med Virol; 1989 Apr; 27(4):274-81. PubMed ID: 2656908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
